Site-specific modifications and toxicity of blood substitutes

This publication has 62 references indexed in Scilit:

• Future prospects for artificial blood
  Trends in Biotechnology, 1999
• Structural characterization of human hemoglobin crosslinked by bis(3,5‐dibromosalicyl) fumarate using mass spectrometric techniques
  Protein Science, 1997
• An Improved Process for the Production of Sterile Modified Haemoglobin Solutions
  Biologicals, 1997
• Resuscitation and the limited utility of the present generation of blood substitutes
  Transfusion Medicine Reviews, 1996
• Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients
  American Journal of Kidney Diseases, 1995
• Hemoglobin and free radicals: implications for the development of a safe blood substitute
  Molecular Medicine Today, 1995
• Virus Inactivation in Hemoglobin Solutions by Heat
  Biomaterials, Artificial Cells and Artificial Organs, 1988
• Diaspirins that crosslink .beta. chains of hemoglobin: bis(3,5-dibromosalicyl) succinate and bis(3,5-dibromosalicyl) fumarate
  Biochemistry, 1979
• A clinical safety trial of stroma‐free hemoglobin
  Clinical Pharmacology & Therapeutics, 1978
• EVALUATION OF A STROMA-FREE HEMOGLOBIN SOLUTION FOR USE AS A PLASMA EXPANDER
  The Journal of Experimental Medicine, 1967